Global /Taiwan /Healthcare /Drug Manufacturers - Specialty & Generic /4732
chevron_leftBack
NatureWise Biotech & Medicals Corp. logo

NatureWise Biotech & Medicals Corp.

4732
TPEX: 4732 Delayed
19.80TWD 0.8%
0.6294 USD
As of 5 June 2026, NatureWise Biotech & Medicals Corp. has a market cap of $29.36M USD, ranking #34403 globally and #2114 in Taiwan. It ranks #3102 in the Healthcare sector, and #187 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
34403
Country Rank
2114
Sector Rank
3102
Industry Rank
187
Key Stats
Market Cap
$29.36MUSD
923.6M TWD
Enterprise Value
$12.21MUSD
384.19M TWD
Revenue (TTM)
$5.73MUSD
180.29M TWD
EBITDA (TTM)
-$1.2MUSD
-37.61M TWD
Net Income (TTM)
-$1.18MUSD
-37.01M TWD
EBITDA Margin
-21%
Profit Margin
-21%
PS Ratio
5.1
PB Ratio
1.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Zhong Yang Huang open_in_new
Employees
31
Founded
1990
Website
naturewise.com.tw open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.8% 0.8% -3.9% -3.7% -2.7% -0.8%

News

Loading...

Markets

Exchange Ticker Price
Taipei Exchange
MIC: ROCO
PRIMARY
4732
彥臣生技藥品股份有限公司
ISIN: TW0004732003
Shares Out.:
48.298M1
TV:
SA:
YF:
GF:
BA:
MS:
19.80 TWD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About NatureWise Biotech & Medicals Corp.

NatureWise Biotech & Medicals Corporation engages in the research and development of Western medicine, Chinese medicine, and biotechnology in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; and green propolis and red yeast rice products. The company was founded in 1990 and is headquartered in Taipei, Taiwan.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Taiwan)
Name
Market Cap diff.
PE
$1.68B
52.95B TWD
6K%
17.9
1707
$536.85M
16.89B TWD
2K%
14.0
$476.38M
14.99B TWD
2K%
36.5
8436
$415.07M
13.06B TWD
1K%
13.7
4128
$291.68M
9.18B TWD
893%
-
7832
$244.3M
7.69B TWD
732%
-
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.93B
108.92B ILS
129K%
24.2
$29.56B
101K%
-
$15.86B
107.34B CNY
54K%
16.0
CIPLA
$11.12B
1.06T INR
38K%
23.4
LUPIN
$11.0B
1.05T INR
37K%
22.7
$9.1B
61.6B CNY
31K%
80.6
chevron_leftBack